Back

Prevalence of cardiovascular disease in Sickle cell disease (SCD)- An echocardiographic and pharmacological analysis

1 December 2022 (08:00 - 19:00)
Organised by:
Congress Presentation Part of: Poster Session 2 Autoimmune/Chronic Inflammatory Disorders and Heart Disease ESC Professional Premium Access ESC Asia 2022 with APSC & AFC

About the speaker

Photo
Doctor Nalin Natarajan

University College of London, London (United Kingdom of Great Britain & Northern Ireland)

32 More presentations in this session

Presentation thumbnail
The single-syringe versus the double-syringe techniques of adenosine administration for supraventricular tachycardia: a systematic review and meta-analysis
Miss I. Miyawaki (Curitiba, BR)
Abstract Slides
Presentation thumbnail
Efficacy and safety of sacubitril/valsartan in patients with acute decompensated heart failure: a systematic review and meta-analysis
Doctor B. David (Global City, PH)
Abstract Slides
Presentation thumbnail
Unexplained heart failure post pulmonary embolism: an observational study
Presentation thumbnail
Estimation of brain natriuretic peptide values from N-terminal pro brain natriuretic peptide levels and other factors
Doctor Y. Kajikawa (Fukuyama, JP)
Abstract Slides
Presentation thumbnail
Clinical characteristics, management, and outcomes of acute heart failure patients in Central Asia.
Doctor T. Abdurashidova (Lausanne, CH)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2

The Event

Event poster

ESC Asia 2022 with APSC & AFC

1 December - 3 December 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources